SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,029,000 | -46.8% | 248,610 | -25.4% | 0.01% | -54.5% |
| Q1 2022 | $1,935,000 | -78.9% | 333,082 | -43.4% | 0.01% | -85.7% |
| Q4 2020 | $9,185,000 | +2562.3% | 588,624 | +1430.7% | 0.08% | +1825.0% |
| Q2 2020 | $345,000 | +255.7% | 38,454 | +277.4% | 0.00% | +33.3% |
| Q1 2019 | $97,000 | -94.8% | 10,190 | -89.6% | 0.00% | -93.2% |
| Q1 2018 | $1,867,000 | -45.1% | 98,244 | -52.6% | 0.04% | -40.5% |
| Q4 2017 | $3,402,000 | – | 207,433 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |